HBV Mutation Detail Information

> L180M Search Result


Mutation Information
Mutation Site L180M
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Combined Mutation rt.M204I+rt.L180M
Viral Reference AM282986
Relevant Drug lamivudine (LAM);entecavir (ETV);telbivudine (LDT);clevudine (CLV)
Literature Information
PubMed PMID 24814823
Published Year 2014
Journal Current opinion in virology
Title Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance.
Author Menéndez-Arias L,Álvarez M,Pacheco B
Evidence Major mutational patterns conferring nucleoside/nucleotide analog resistance include the combinations rtL180M/rtM204(I/V) (for lamivudine, entecavir, telbivudine and clevudine) and rtA181V/rtN236T (for adefovir and tenofovir).

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation